Cargando…

An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue

The altered form of the high-mobility group A2 (HMGA2) gene is somehow related to the generation of human benign and malignant tumours of mesenchymal origin. However, only a few data on the expression of HMGA2 in malignant tumour originating from epithelial tissue are available. In this study, we ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abe, N, Watanabe, T, Suzuki, Y, Matsumoto, N, Masaki, T, Mori, T, Sugiyama, M, Chiappetta, G, Fusco, A, Atomi, Y
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376847/ https://www.ncbi.nlm.nih.gov/pubmed/14647145 http://dx.doi.org/10.1038/sj.bjc.6601391

Ejemplares similares

Overexpression of TGF-β by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer
por: Aoyagi, Y, et al.
Publicado: (2004)

Nuclear BAG-1 expression reflects malignant potential in colorectal carcinomas
por: Kikuchi, R, et al.
Publicado: (2002)

Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions-
por: Tajima, Y, et al.
Publicado: (2004)

Detection of human papillomavirus-16 in ovarian malignancy
por: Wu, Q-J, et al.
Publicado: (2003)

Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer
por: Kronqvist, P, et al.
Publicado: (2002)

Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells
por: Niizeki, H, et al.
Publicado: (2002)

Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma
por: Suzuoki, M, et al.
Publicado: (2002)

Differential gene-expression profiles associated with gastric adenoma
por: Takenawa, H, et al.
Publicado: (2004)

Carcinoma-like vascular density in atypic keratoacanthoma suggests malignant progression
por: Strieth, S, et al.
Publicado: (2002)

Specific T-cell immunity against Ki-ras peptides in patients with pancreatic and colorectal cancers
por: Shono, Y, et al.
Publicado: (2003)

Impaired ΔNp63 expression associates with reduced β-catenin and aggressive phenotypes of urothelial neoplasms
por: Koga, F, et al.
Publicado: (2003)

Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation
por: Vivo, C, et al.
Publicado: (2003)

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells
por: Kim, M, et al.
Publicado: (2003)

Purified malignant mammary epithelial cells maintain hormone responsiveness in culture
por: Kothari, M S, et al.
Publicado: (2003)

Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling
por: Lee, Y-F, et al.
Publicado: (2003)

Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-γ in haematopoietic tumour cells
por: Morimoto, Y, et al.
Publicado: (2004)

Allelic loss at 19q12 and Xq11–12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential
por: Nakayama, K, et al.
Publicado: (2004)

Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours
por: Yoshida, T, et al.
Publicado: (2004)

Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix
por: Nakagawa, S, et al.
Publicado: (2004)

Phosphorylated tyrosine-containing proteins in primary lung cancer correlates with proliferation and prognosis
por: Gong, Y, et al.
Publicado: (2002)

KOC is a novel molecular indicator of malignancy
por: Mueller, F, et al.
Publicado: (2003)

Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA
por: Maire, F, et al.
Publicado: (2002)

The prognostic influence of bcl-2 in malignant glioma
por: McDonald, F E, et al.
Publicado: (2002)

Lymphatic density and metastatic spread in human malignant melanoma
por: Shields, J D, et al.
Publicado: (2004)

Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with Mlh1 expression and gastric phenotype
por: Kawaguchi, K, et al.
Publicado: (2004)

Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma
por: Ogawa, K, et al.
Publicado: (2004)

MUC4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGFβ2
por: Choudhury, A, et al.
Publicado: (2004)

Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer
por: Sagara, Y, et al.
Publicado: (2004)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus
por: Kasamatsu, T, et al.
Publicado: (2003)

UDP-Gal: βGlcNAc β1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour
por: Tsuda, N, et al.
Publicado: (2002)

Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells
por: Hsieh, S Y, et al.
Publicado: (2003)

Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells
por: Trauzold, A, et al.
Publicado: (2003)

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma
por: Rohloff, J, et al.
Publicado: (2002)

Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters
por: Watanabe, J, et al.
Publicado: (2002)

L523S, an RNA-binding protein as a potential therapeutic target for lung cancer
por: Wang, T, et al.
Publicado: (2003)

Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma
por: Ito, Y, et al.
Publicado: (2004)

Clinical significance of transmembrane 4 superfamily in colon cancer
por: Hashida, H, et al.
Publicado: (2003)

Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker
por: Salazar-Onfray, F, et al.
Publicado: (2002)

Identification of mRNAs differentially-expressed between benign and malignant breast tumour cells
por: Liu, D, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_9ma8ue34u7nm0m5215nv0p91hc